Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Article

The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)

Maria Eckart, Ulf-Peter Guenther, Jan Idkowiak, Raymonda Varon, Benjamin Grolle, Patrizia Boffi, Lionel Van Maldergem, Christoph Hübner, Markus Schuelke and Katja von Au
Pediatrics January 2012, 129 (1) e148-e156; DOI: https://doi.org/10.1542/peds.2011-0544
Maria Eckart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulf-Peter Guenther
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Idkowiak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymonda Varon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Grolle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizia Boffi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Van Maldergem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Hübner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schuelke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja von Au
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF

Abstract

Background: Only scarce information is available on the long-term outcome and the natural course of children with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) due to mutations in the IGHMBP2 gene.

Objective: To describe the natural disease course, to systematically quantify the residual capacities of children with SMARD1 who survive on permanent mechanical respiration, and to identify markers predicting the disease outcome at the time of manifestation.

Methods: We conducted a longitudinal study of 11 infantile SMARD1 patients over a mean observational period of 7.8 (SD 3.2) years. Disease-specific features were continuously assessed by using a semiquantitative scoring system. Additionally, we analyzed the residual enzymatic activity of 6 IGHMBP2 mutants in our patients.

Results: After an initial rapid decline of the clinical score until the age of 2 years, residual capabilities reached a plateau or even improved. The overall clinical outcome was markedly heterogeneous, but clinical scores at the age of 3 months showed a positive linear correlation with the clinical outcome at 1 year and at 4 years of age. If expressed in an in vitro recombinant system, mutations of patients with more favorable outcomes retained residual enzymatic activity.

Conclusions: Despite their severe disabilities and symptoms, most SMARD1 patients are well integrated into their home environment and two thirds of them are able to attend kindergarten or school. This information will help to counsel parents at the time of disease manifestation.

KEY WORDS
  • diaphragmatic paralysis
  • distal muscular weakness
  • natural disease course, neuromuscular disease
  • SMARD1
  • Abbreviations:
    DSMA —
    distal spinal muscular atrophy
    DSMA1 —
    distal spinal muscular atrophy type 1
    IGHMBP2 —
    immunoglobulin μ-binding protein 2
    OMIM —
    Online Mendelian Inheritance of Man
    SMA —
    spinal muscular atrophy
    SMARD1 —
    spinal muscular atrophy with respiratory distress type 1
    • Accepted September 7, 2011.
    • Copyright © 2012 by the American Academy of Pediatrics

    Individual Login

    Log in
    You will be redirected to aap.org to login or to create your account.

    Institutional Login

    via Institution

    You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

    Log in through your institution

    If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

    Purchase access

    You may purchase access to this article. This will require you to create an account if you don't already have one.

    Offer Reprints

    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 129, Issue 1
    1 Jan 2012
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)
    Maria Eckart, Ulf-Peter Guenther, Jan Idkowiak, Raymonda Varon, Benjamin Grolle, Patrizia Boffi, Lionel Van Maldergem, Christoph Hübner, Markus Schuelke, Katja von Au
    Pediatrics Jan 2012, 129 (1) e148-e156; DOI: 10.1542/peds.2011-0544

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)
    Maria Eckart, Ulf-Peter Guenther, Jan Idkowiak, Raymonda Varon, Benjamin Grolle, Patrizia Boffi, Lionel Van Maldergem, Christoph Hübner, Markus Schuelke, Katja von Au
    Pediatrics Jan 2012, 129 (1) e148-e156; DOI: 10.1542/peds.2011-0544
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Abstract
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Supplemental
    • Info & Metrics
    • Comments

    Related Articles

    • PubMed
    • Google Scholar

    Cited By...

    • Case of paediatric neuromuscular disease with a surprising clinical outcome: time to challenge the dogma?
    • Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
    • Recessive truncating IGHMBP2 mutations presenting as axonal sensorimotor neuropathy
    • Defects of RNA metabolism in the pathogenesis of spinal muscular atrophy
    • Google Scholar

    More in this TOC Section

    • Applications of Artificial Intelligence for Retinopathy of Prematurity Screening
    • Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
    • A Prevention Program for Insomnia in At-risk Adolescents: A Randomized Controlled Study
    Show more Article

    Similar Articles

    Subjects

    • Pulmonology
      • Pulmonology
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics